Literature DB >> 11181366

Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids.

B Auclair1, D E Nix, R D Adam, G T James, C A Peloquin.   

Abstract

This study was conducted in order to (i) determine the effect of food, orange juice, or antacids on the absorption of a single oral 500-mg dose of ethionamide (ETA) in healthy volunteers, including an assessment of bioequivalence, and (ii) determine ETA population pharmacokinetic (PK) parameters. The pharmacokinetics of ETA in serum was determined for 12 healthy males and females in a randomized, four-period crossover study. Volunteers received single 500-mg doses of ETA either on an empty stomach (reference) or with food, orange juice, or antacids. Serum samples were collected for 48 h and assayed by high-performance liquid chromatography. Data were analyzed by noncompartmental and population methods. Mean test/reference ratios and 90% confidence intervals were determined. No statistically significant differences were seen in the maximum concentration of ETA (C(max)), time to maximum concentration (T(max)), or area under the concentration-time curve from 0 h to infinity (AUC(0-infinity)) between the four treatments (P > 0.05 by analysis of variance). The least-squares mean ratios (with confidence intervals in parentheses) for C(max) were 105% (81.2 to 135%) after orange juice, 94% (72.8 to 121%) after food, and 88% (68.4 to 114%) after antacids. The least-squares mean ratios (with confidence intervals is in parentheses) for AUC(0-infinity) were 91% (72.7 to 115%) after orange juice, 96% (76.4 to 121%) after food, and 95% (75.5 to 120%) after antacids. The mean T(max) was slightly prolonged following antacid or food administration (2.3 to 2.6 h) compared to administration on an empty stomach or with juice (1.7 to 1.9 h). The median population PK parameters were as follows: K(a) = 0.37 to 0.48 h(-1), V/F = 2.0 to 2.8 liters/kg, CL/F = 56.5 to 72.2 liters/h, and terminal half-life = 1.7 to 2.1 h, where K(a) is the absorption rate constant, V is the volume of distribution, and CL is clearance. The PK behavior of ETA was not significantly modified by the different conditions studied. Mean ratios for AUC ranged from 0.91 to 0.96 for the orange juice, food, and antacid treatments, indicating a minimal effect on relative bioavailability. ETA can, therefore, be administered with food if tolerance is an issue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181366      PMCID: PMC90379          DOI: 10.1128/AAC.45.3.810-814.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids.

Authors:  C A Peloquin; R Namdar; A A Dodge; D E Nix
Journal:  Int J Tuberc Lung Dis       Date:  1999-08       Impact factor: 2.373

Review 2.  Understanding bioequivalence testing.

Authors:  L Z Benet
Journal:  Transplant Proc       Date:  1999-05       Impact factor: 1.066

3.  BLOOD ETHIONAMIDE LEVELS AFTER ADMINISTRATION OF ENTERIC-COATED AND UNCOATED TABLETS.

Authors:  J A GROENROOS; A TOIVANEN
Journal:  Curr Ther Res Clin Exp       Date:  1964-02

4.  ETHIONAMIDE AND ISONIAZID IN PREVIOUSLY UNTREATED CASES OF PULMONARY TUBERCULOSIS.

Authors:  A W LEES
Journal:  Dis Chest       Date:  1964-03

5.  The absorption and toxicity of ethionamide.

Authors:  H J WEINSTEIN; W Y HALLETT; A S SARAUW
Journal:  Am Rev Respir Dis       Date:  1962-10

6.  Isoniazid and ethionamide serum levels and inactivation in Finnish subjects.

Authors:  H Tiitinen
Journal:  Scand J Respir Dis       Date:  1969

7.  Comparison of ethionamide with isoniazid in original treatment cases of pulmonary tuberculosis. XIV. A report of the Veterans Administration--Armed Forces cooperative study.

Authors:  W S Schwartz
Journal:  Am Rev Respir Dis       Date:  1966-05

8.  Once-daily and twice-daily dosing of p-aminosalicylic acid granules.

Authors:  C A Peloquin; S E Berning; G A Huitt; J M Childs; M D Singleton; G T James
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

9.  [Identification of 3 new metabolites of ethionamide: chromatography, spectrophotometry, polarography].

Authors:  A Bieder; P Brunel; L Mazeau
Journal:  Ann Pharm Fr       Date:  1966 Jul-Aug

10.  Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids.

Authors:  C A Peloquin; R Namdar; M D Singleton; D E Nix
Journal:  Chest       Date:  1999-01       Impact factor: 9.410

View more
  12 in total

Review 1.  Clinically significant drug interactions with antacids: an update.

Authors:  Ryuichi Ogawa; Hirotoshi Echizen
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

Review 2.  Therapeutic drug monitoring in the treatment of tuberculosis: an update.

Authors:  Abdullah Alsultan; Charles A Peloquin
Journal:  Drugs       Date:  2014-06       Impact factor: 9.546

3.  Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs.

Authors:  Lucila Garcia-Contreras; Danielle J Padilla-Carlin; Jean Sung; Jarod VerBerkmoes; Pavan Muttil; Katharina Elbert; Charles Peloquin; David Edwards; Anthony Hickey
Journal:  J Pharm Sci       Date:  2016-11-11       Impact factor: 3.534

4.  Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis.

Authors:  Devyani Deshpande; Jotam G Pasipanodya; Stellah G Mpagama; Shashikant Srivastava; Paula Bendet; Thearith Koeuth; Pooi S Lee; Scott K Heysell; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2018-11-28       Impact factor: 9.079

5.  Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant Tuberculosis.

Authors:  Mohammad H Al-Shaer; Anne-Grete Märtson; Wael A Alghamdi; Abdullah Alsultan; Guohua An; Shahriar Ahmed; Yosra Alkabab; Sayera Banu; Eric R Houpt; David Ashkin; David E Griffith; J Peter Cegielski; Scott K Heysell; Charles A Peloquin
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

Review 6.  Therapeutic drug monitoring in the treatment of tuberculosis.

Authors:  Charles A Peloquin
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Pharmacokinetics of ethionamide in children.

Authors:  S Thee; H I Seifart; B Rosenkranz; A C Hesseling; K Magdorf; P R Donald; H S Schaaf
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

8.  Population Pharmacokinetics and Dosing of Ethionamide in Children with Tuberculosis.

Authors:  Henrik Bjugård Nyberg; Heather R Draper; Anthony J Garcia-Prats; Stephanie Thee; Adrie Bekker; Heather J Zar; Andrew C Hooker; H Simon Schaaf; Helen McIlleron; Anneke C Hesseling; Paolo Denti
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.938

9.  Effect of Isoniazid Intake on Ethionamide Pharmacokinetics and Target Attainment in Multidrug-Resistant Tuberculosis Patients.

Authors:  Maxwell T Chirehwa; Richard Court; Mariana de Kock; Lubbe Wiesner; Nihal de Vries; Joseph Harding; Tawanda Gumbo; Gary Maartens; Rob Warren; Paolo Denti; Helen McIlleron
Journal:  Antimicrob Agents Chemother       Date:  2021-07-26       Impact factor: 5.191

10.  Physicochemical properties of dietary phytochemicals can predict their passive absorption in the human small intestine.

Authors:  Sophie N B Selby-Pham; Rosalind B Miller; Kate Howell; Frank Dunshea; Louise E Bennett
Journal:  Sci Rep       Date:  2017-05-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.